SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis

BACKGROUND: In Belgium, COVID-19 epidemy began on February 4, 2020 with a peak on April 10, 2020. Patients with cystic fibrosis (CF) followed in the Cliniques universitaires Saint-Luc were rapidly isolated before the government lockdown. METHODS: After the peak of the epidemy, we measured anti-SARS-...

Descripción completa

Detalles Bibliográficos
Autores principales: Berardis, S., Verroken, A., Vetillart, A., Struyf, C., Gilbert, M., Gruson, D., Gohy, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. Published by Elsevier B.V. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418700/
https://www.ncbi.nlm.nih.gov/pubmed/32828701
http://dx.doi.org/10.1016/j.jcf.2020.08.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418700/
https://www.ncbi.nlm.nih.gov/pubmed/32828701
http://dx.doi.org/10.1016/j.jcf.2020.08.005

Ejemplares similares